Bcel stock forecast.

Zacks' 7 Strongest Buys for December, 2023. Our experts just released their predictions for 7 stocks likely to climb the highest in the next 30-90 days. Chosen from the market-doubling list of ...Find real-time ALLK - Allakos Inc stock quotes, company profile, news and forecasts from CNN Business.The Cymabay Therapeutics Inc stock price gained 1.86% on the last trading day (Thursday, 30th Nov 2023), rising from $18.78 to $19.13. During the last trading day the stock fluctuated 4.76% from a day low at $18.89 to a day high of $19.79. The price has risen in 6 of the last 10 days and is up by 6.28% over the past 2 weeks.According to . 3 Wall Street analysts that have issued a 1 year BCEL price target, the average BCEL price target is $9.00, with the highest BCEL stock price forecast at $25.00 and the lowest BCEL stock price forecast at $1.00.

Understanding stock price lookup is a basic yet essential requirement for any serious investor. Whether you are investing for the long term or making short-term trades, stock price data gives you an idea what is going on in the markets.Stock Price Forecast. The 8 analysts offering 12-month price forecasts for EyePoint Pharmaceuticals Inc have a median target of 28.00, with a high estimate of 55.00 and a low estimate of 20.00 ...

BCEL Overview Stock Screener Earnings Calendar Sectors Nasdaq | BCEL U.S.: Nasdaq Atreca Inc. Cl A Watch Set a price target alert After Hours Last Updated: Nov 17, 2023 …Atreca, Inc. (BCEL.NASDAQ) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Atreca, Inc. | Nasdaq: BCEL | Nasdaq

1 analysts 33.33% Hold 2 analysts 66.67% Sell 0 analysts 0% Strong Sell 0 analysts 0% Be the first to know when Wall Street analysts revise their BCEL stock forecasts and price …According to the issued ratings of 5 analysts in the last year, the consensus rating for Atreca stock is Hold based on the current 4 hold ratings and 1 buy rating for BCEL. The average twelve-month price prediction for Atreca is $10.75 with a high price target of $25.00 and a low price target of $4.00. Learn more on BCEL's analyst rating history.Oct 27, 2023 · Forecst.com predicts future values using technical analysis of a large number of analytical parameters. BCEL stock returns are also predicted based on historical data. According to our research, BCEL stock is a bad long-term investment. BCEL share price has been in a bear cycle for the past year. Atreca, Inc. stock trend is negative . Weather forecasts play an essential role in our daily lives, helping us plan our activities and stay prepared for any weather conditions that may come our way. One of the most common types of forecasts is the 7-day weather forecast, which p...11.30% of Atreca stock is owned by insiders. Which Atreca insiders have been selling company stock? The following insiders have sold BCEL shares in the last 24 months: Bros. Advisors Lp Baker ($109,895.60), John A Orwin ($37,216.24), Phillips Courtney ($15,321.16), and Tito Serafini ($199,122.53).

Atreca (BCEL) suspends the development of only pipeline candidate, ATRC-101, in clinical evaluation, as part of its business restructuring efforts and cuts headcount by 40%. The stock falls 37%.

Stock Price Forecast. According to 4 stock analysts, the average 12-month stock price forecast for Atreca stock is $3.38, which predicts an increase of 1,509.52%. …

Stock Price Forecast. The 17 analysts offering 12-month price forecasts for BCE Inc have a median target of 41.19, with a high estimate of 45.64 and a low estimate of 39.16. The median estimate ...BCEL stock forecast Our latest prediction for Atreca Inc's stock price was made on the Aug. 7, 2023 when the stock price was at 0.91$.. In the short term (2weeks), BCEL's stock price should underperform the market by -3.07%.During that period the price should oscillate between -9.61% and +7.63%.. In the medium term (3months), BCEL's …We've seen plenty of personal finance tools designed to help you track what you're spending, but web site PocketSmith is an impressive new web-based personal finance tool with an emphasis on forecasting your financial future. We've seen ple...msn.com - August 11 at 5:24 PM. Atreca Reports Second Quarter 2023 Financial Results and Announces Corporate Restructuring. finance.yahoo.com - August 11 at 12:47 AM. Atreca Inc - (BCEL) Price Target Increased by 11.89% to 10.20. msn.com - August 2 at 12:44 PM. Atreca Approaches A Major Go/No-Go Decision.Find real-time CBAY - CymaBay Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business.On May 10, 2023, Atreca (NASDAQ:BCEL) announced its financial results for the first quarter of the year. The company reported Atreca Reports Q1 2023 Financial Results with Exceeding Analyst Estimates - Best Stocks

Explore BCEL - Atreca Inc Stock Price Forecast: Accurate short-term and long-term price predictions up to 2050Throughout the U.S., the weather can be quite unpredictable, even with state-of-the-art radar, sensors and computer modeling technology right at meteorologists’ fingertips. The Old Farmer’s Almanac first provided valuable statistics and dat...Stock Price Forecast. The 17 analysts offering 12-month price forecasts for BCE Inc have a median target of 41.19, with a high estimate of 45.64 and a low estimate of 39.16. The median estimate ...Atreca, Inc. (BCEL.NASDAQ) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Atreca, Inc. | Nasdaq: BCEL | NasdaqThe current average BCEL price target, as estimated by these analysts, is $4.00. The predictions for the future BCEL stock price range from a low of $4.00 to a high of $4.00, highlighting the variability of market expectations for BCEL.Stock Price Forecast. The 4 analysts offering 12-month price forecasts for Heron Therapeutics Inc have a median target of 5.50, with a high estimate of 9.00 and a low estimate of 2.50. The median ...

HOOK Stock 12 Months Forecast. $6.83. (1382.20% Upside) Based on 3 Wall Street analysts offering 12 month price targets for Hookipa Pharma in the last 3 months. The average price target is $6.83 with a high forecast of $7.00 and a low forecast of $6.50. The average price target represents a 1382.20% change from the last price of $0.46.

Last reporting date. November 13, 2023. EPS forecast (this quarter) -$68.00. Annual revenue (last year) $1.1B. Annual profit (last year) -$415.6M. Net profit margin.According to the issued ratings of 5 analysts in the last year, the consensus rating for Atreca stock is Hold based on the current 4 hold ratings and 1 buy rating for BCEL. The average twelve-month price prediction for Atreca is $10.75 with a high price target of $25.00 and a low price target of $4.00. Learn more on BCEL's analyst rating history.5 equities research analysts have issued twelve-month target prices for Atreca's stock. Their BCEL share price targets range from $4.00 to $25.00. On average, they expect the company's stock price to reach $10.75 in the next twelve months. This …Nov 10, 2023 · The latest Atreca stock prices, stock quotes, news, and BCEL history to help you invest and trade smarter. ... The 11 analysts offering price forecasts for Atreca have a median target of 11.77 ... Atreca, Inc. (BCEL.NASDAQ) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Atreca, Inc. | Nasdaq: BCEL | NasdaqStock Price Forecast. The 8 analysts offering 12-month price forecasts for EyePoint Pharmaceuticals Inc have a median target of 28.00, with a high estimate of 55.00 and a low estimate of 20.00 ... Zacks News for BCEL Atreca (BCEL) Suspends Lead Drug Evaluation, Stock Falls 37% 08/14/23-9:51AM EST Zacks Here's Why Atreca, Inc. (BCEL) Is a Great 'Buy the Bottom' Stock Now 04/06/23-8:55AM EST ...In 2021 and 2020, respectively 14 and 13 companies raised sums of $250m or more, whilst in 2019 and 2018, the numbers were 3 and 2. Atreca Inc ( NASDAQ: BCEL) IPOd in June 2019, raising ~$114m at ...According to the National Snow & Ice Data Center, blizzard prediction relies on modeling weather systems, as well as predicting temperatures. The heavy snowfall that blizzards create can be hard to predict in advance.

Earnings Summary. For their last quarter, Atreca (BCEL) reported earnings of -$0.49 per share, beating the Zacks Consensus Estimate of $-0.56 per share. This reflects a positive earnings surprise ...

msn.com - August 11 at 5:24 PM. Atreca Reports Second Quarter 2023 Financial Results and Announces Corporate Restructuring. finance.yahoo.com - August 11 at 12:47 AM. Atreca Inc - (BCEL) Price Target Increased by 11.89% to 10.20. msn.com - August 2 at 12:44 PM. Atreca Approaches A Major Go/No-Go Decision.

Stock Target Advisor’s own stock analysis of Atreca Inc is Bearish, which is based on 1 positive signals and 6 negative signals. At the last closing, Atreca Inc’s stock price was USD 0.22. Atreca Inc’s stock price has changed by -5.11% over the past week, +8.25% over the past month and -79.54% over the last year.Find real-time BCE - BCE Inc stock quotes, company profile, news and forecasts from CNN Business. Li Auto Inc - ADR Stock Forecast, LI stock price prediction. Price target in 14 days: 44.695 USD. The best long-term & short-term Li Auto Inc - ADR share price ... Over the last year, the company’s stock hit its highest at $2.05 on 01/31/23, while the lowest price during the same time frame was $0.21, recorded on 10/09/23. 52-week price history of BCEL Stock. The history of a stock’s 52-week high and low prices can provide important information about its current state and future potential.Cymabay Therapeutics Inc () Stock Market info Recommendations: Buy or sell Cymabay Therapeutics stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Cymabay Therapeutics share forecasts, stock quote and buy / sell signals below.According to present data Cymabay Therapeutics's CBAY shares and potentially …We’ve all flipped between different weather apps, wondering why each is giving a slightly different report. Before we look at AccuWeather, it’s important to understand the basics of weather forecasting. In the past, weather predictions were...QFIN Stock 12 Months Forecast. $25.75. (85.12% Upside) Based on 2 Wall Street analysts offering 12 month price targets for Qifu Technology in the last 3 months. The average price target is $25.75 with a high forecast of $27.00 and a low forecast of $24.50. The average price target represents a 85.12% change from the last price of $13.91.Atreca, Inc. (BCEL) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock ...The rating of the stock has changed to hold according to some analysts. It's at an all time low, buy folks thanks me later. Recently BCEL has reached an all time low and a data suggests that is will rise back up. According to Fintel.IO Blackrock has bought a staggering 350k shares. The rating of the stock has changed to hold according to some ... Stock Price Forecast. The 4 analysts offering 12-month price forecasts for Atreca Inc have a median target of 1.50, with a high estimate of 9.00 and a low estimate of 1.00. The median estimate represents a +500.00% increase from the last price of 0.25. Qifu Technology (NASDAQ:QFIN) pays an annual dividend of $0.98 per share and currently has a dividend yield of 6.10%. QFIN has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 28.16%. This payout ratio is at a healthy, sustainable level, below 75%.Stock Price Forecast. According to 4 stock analysts, the average 12-month stock price forecast for Atreca stock is $3.38, which predicts an increase of 1,509.52%. …

Nov 6, 2023 · Analyst projections state that BCEL is forecast to be at a low of $1.00 and a high of $9.00. In order for the stock price to hit the forecast high, the stock would need to plunge -3361.54% from its current level, while the stock would need to crash -284.62% from its current level to reach the projected low. Atreca Inc (BCEL) estimates and forecasts The current Atreca [ BCEL] share price is $0.21. The Score for BCEL is 45, which is 10% below its historic median score of 50, and infers higher risk than normal. BCEL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.231.40. -1.20%. 108.31K. Find the latest Atreca Inc (BCEL) stock forecast, 12-month price target, predictions and analyst recommendations.Instagram:https://instagram. where to trade micro futuresalarm stocktop 10 prop firmsaerospace stock Zacks News for BCEL Atreca (BCEL) Suspends Lead Drug Evaluation, Stock Falls 37% 08/14/23-9:51AM EST Zacks Here's Why Atreca, Inc. (BCEL) Is a Great 'Buy the Bottom' Stock Now 04/06/23-8:55AM EST ... day trade no minimuminvesting books for beginners See Atreca, Inc. (BCEL) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.Read Full Company Summary for BCEL here. View Atreca, Inc BCEL investment & stock information. Get the latest Atreca, Inc BCEL detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. stock picks ATRECA, INC. stock price forecast for further price development down to -100.00% (time horizon: 1 day) and price target of 0.00 USD. Negative news sentiment. Short-term (time horizon: 2 weeks) ATRECA, INC. share price prediction for 2024-01-12 with daily closed price projectionsAtreca, Inc. (BCEL) stock forecast and price target. Find the latest Atreca, Inc. BCEL analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports.